Comparative observation of the effectiveness and safety of remimazolam besylate versus dexmedetomidine in gastrointestinal surgery in obese patients

Table 1 Background information on obese patients undergoing gastrointestinal surgery

Factors	Con (n = 30)	Res (n = 30)	χ2 or t-test result	P value
Age (yr)	38.13 ± 6.05	39.38 ± 6.72	0.757	0.452
Sex (male/female)	13/17	14/16	0.067	0.795
BMI (kg/m2)	32.05 ± 2.80	32.05 ± 2.80	0.673	0.504
ASA classification (I/II)	20/10	17/13	0.635	0.426
Educational level (below high school/high school and above)	22/8	17/13	1.832	0.176

Results are presented as mean ± SD or numbers and percentages. ASA: American Society of Anesthesiologists; BMI: Body mass index; Con: Control group; Res: Research group.

Table 2 Safety of obese patients undergoing gastrointestinal surgery, n (%)

Adverse event	Con (n = 30)	Res (n = 30)	χ2	P value
Nausea and vomiting	2 (6.67)	0 (0.00)
Bradycardia	4 (13.33)	2 (6.67)
Hypotension	3 (10.00)	1 (3.33)
Apnea	2 (6.67)	1 (3.33)
Total	11 (36.67)	4 (13.33)	4.356	0.037

Con: Control group; Res: Research group.